Watch BMRA. Know when insiders buy.
One email the day a filing lands. Free.
BMRA
BIOMERICA INC
1.71
−0.01 −0.58%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · insiders 83, shorts 0
Insiders, 90 days
+$158K
net buying · 5 buys, 0 sells · cluster
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $7.9MP/E —DIV YIELD —FCF YIELD —REV TTM $4.5M −16.2%NET INCOME −$3.8MNET CASH —52W 1.49 – 3.20SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2026 · May 31derived | $875K | +16.8% | -8.1% | −$1.5M | −$1.1M | — | -0.38 | −$912K | — | — | Aug 31 |
| Q3 2026 · Feb 28 | $987K | −11.8% | -4.5% | −$1.3M | −$1.3M | — | -0.44 | −$1.3M | — | — | Apr 13 |
| Q2 2026 · Nov 30 | $1.2M | −26.0% | 4.2% | −$1.4M | −$1.3M | — | -0.45 | −$991K | — | — | Apr 13 |
| Q1 2026 · Aug 31 | $1.4M | −23.6% | 30.7% | −$1.1M | $2K | — | 0.00 | −$268K | — | — | Apr 13 |
| Q4 2025 · May 31derived | $749K | −32.9% | -32.6% | −$1.6M | −$1.5M | — | -0.69 | −$662K | — | — | Aug 31 |
| Q3 2025 · Feb 28 | $1.1M | +10.0% | 1.7% | −$1.2M | −$1.2M | — | -0.48 | −$1M | — | — | Apr 13 |
| Q2 2025 · Nov 30 | $1.6M | +4.4% | 26.7% | −$993K | −$950K | — | -0.06 | −$791K | — | — | Apr 13 |
| Q1 2025 · Aug 31 | $1.8M | +5.5% | 16.0% | −$1.4M | −$1.3M | — | -0.63 | −$1.3M | — | — | Apr 13 |
| Q4 2024 · May 31derived | $1.1M | — | 1.8% | −$1.5M | −$1.4M | — | -2.57 | −$1M | $24K | −$1.1M | Aug 29 |
| Q3 2024 · Feb 29 | $1M | — | -14.7% | −$2M | −$1.9M | — | -0.11 | −$1.8M | $0 | −$1.8M | Apr 14 |
| Q2 2024 · Nov 30 | $1.6M | — | 20.7% | −$1.6M | −$1.5M | — | -0.09 | −$842K | $6K | −$848K | Apr 14 |
| Q1 2024 · Aug 31 | $1.7M | — | 24.1% | −$1.2M | −$1.1M | — | -0.07 | −$1.7M | $21K | −$1.7M | Apr 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to May 31 | $4.5M | 8.1% | −$5.3M | −$3.8M | -84.8% | -1.30 | −$3.4M | — | — | — | — |
| FY2025 · to May 31 | $5.3M | 9.4% | −$5.1M | −$5M | -93.6% | -2.16 | −$3.8M | — | — | — | — |
| FY2024 · to May 31 | $5.4M | 11.3% | −$6.4M | −$6M | -110.4% | -2.84 | −$5.4M | $51K | −$5.4M | — | — |
| FY2023 · to May 31 | $5.3M | 8.4% | −$7.2M | −$7.1M | -133.7% | -0.50 | −$5.5M | $64K | −$5.5M | — | — |
| FY2022 · to May 31 | $18.9M | 15.8% | −$4.5M | −$4.5M | -24.0% | -0.36 | −$479K | $57K | −$536K | — | — |
| FY2021 · to May 31 | $7.2M | 5.1% | −$7.5M | −$7.4M | -103.4% | -0.62 | −$5.3M | $136K | −$5.4M | — | — |
Every number comes from BIOMERICA INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.